April 7, 2025 New data bolstering the anti-inflammatory effect of NeuroRestore ACD856 presented at Alzheimer’s conference
April 2, 2025 New scientific article in Nature linking the potential use of NeuroRestore ACD856 for the treament of obesity
February 24, 2025 New article showing the unique mechanism of action behind Alzstatin as an Alzheimer’s treatment
February 17, 2025 AlzeCure receives EU grant for Phase 2 clinical trial of NeuroRestore ACD856 for Alzheimer’s disease
January 21, 2025 AlzeCure receives abstract acceptance at Alzheimer’s congress AD/PD 2025 on NeuroRestore ACD856
